3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Breast
1
Conditions
Uveal Melanoma
1
Peutz-Jeghers Syndrome
1
Pancreatitis, Chronic
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Non-small Cell Lung Cancer Metastatic
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma
1
Leukemia
1
Hip Fractures
1
Fractures, Spontaneous
1
Dysplastic Nevus Syndrome
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
COVID-19
1
Breast Neoplasms
1
Ataxia Telangiectasia
1
Interventions
Cyclophosphamide
16
fludarabine
9
fludarabine phosphate
8
Whole-Body Irradiation
5
Rituximab
5
Peripheral Blood Stem Cell Transplantation
5
Mycophenolic Acid
5
Busulfan
5
Melphalan
4
Etoposide
4
Cytarabine
4
Azacitidine
4
AP 1903 reagent
4
ruxolitinib
3
ibrutinib
3
Tacrolimus
3
Prednisone
3
Methotrexate
3
Mesna
3
Cyclosporine
3
venetoclax
2
pegaspargase
2
obinutuzumab
2
ivosidenib
2
Vincristine
2
Patient Reported Outcome Measures
2
Observation
2
Mercaptopurine
2
Leucovorin
2
Doxorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Leukemia
×
Data Collection
×
Clear all
NCT04541212
2025-06-15
CarChem
Montreal Heart Institute
Active not recruiting
169 enrolled